前收市價 | 2.9700 |
開市 | 3.0000 |
買盤 | 2.7900 x 100 |
賣出價 | 2.8900 x 100 |
今日波幅 | 2.7500 - 3.0800 |
52 週波幅 | 0.7050 - 6.8500 |
成交量 | |
平均成交量 | 244,801 |
市值 | 41.251M |
Beta 值 (5 年,每月) | 1.02 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.6700 |
業績公佈日 | 2024年7月12日 - 2024年7月16日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 10.00 |
Let me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance. Investing in A-rated biotech stocks offers high return potential if they make significant advancements in health care. Biotech stocks represent companies that are involved in the research and development of drugs, therapies and medical devices. They include companies that work in fields such as genomics, biopharmaceuticals, bioinformatics and me
A-rated penny stocks could be ideal investment opportunities to help growth stock investors expand their portfolios. While these stocks can be risky because of their volatile nature, they also offer unique benefits for investors. Penny stocks aren’t just a penny — in fact, a stock qualifies as a penny stock if shares are less than $5 each. So it’s not usually as if you can buy 100 shares for just a dollar. But in reality, penny stock shares are the cheapest stocks you can buy. For a growth inves